Antihyperlipidemic Effect of Ginsenoside Rg1 in Type 2 Diabetic Mice |
Park, Jae-Hong
(School of Korean Medicine, Pusan National University)
Lee, Ji-Youn (School of Korean Medicine, Pusan National University) Yeo, Ji-Young (School of Korean Medicine, Pusan National University) Nam, Jeong-Su (School of Korean Medicine, Pusan National University) Jung, Myeong-Ho (School of Korean Medicine, Pusan National University) |
1 | Kim, S. J., H. D. Yuan, and S. H. Chung. 2010. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. Biol. Pharm. Bull. 33, 325-328. DOI |
2 | Lee, S. M., H. J. Shon, C. S. Choi, T. M. Hung, B. S. Min, and K. Bae. 2009. Ginsenosides from heat processed ginseng. Chem. Pharm. Bull. (Tokyo) 57, 92-94. DOI |
3 | Liu, G., B. Wang, J. Zhang, H. Jiang, and F. Liu. 2009. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression. J. Ethnopharmacol. 126, 350-354. DOI |
4 | Aasum, E., A. D. Hafstad, D. L. Severson, and T. S. Larsen. 2003. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52, 434-441. DOI |
5 | American Institute of Nutrition. 1980. Report of Ad Hoc committee on standards for nutritional studies. J. Nutr. 110, 1717-1726. |
6 | American Institute of Nutrition. 1977. Report of the American institute of nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 107, 1340-1348. |
7 | Andallu, B., A. V. Vinay Kumar, and NCh. Varadacharyulu. 2009. Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Int. J. Diabetes Dev. Ctries. 29, 123-128. DOI |
8 | Anhauser, M. 2003. Pharmacists seek the solution of a shaman. Drug Discov. Today 8, 868-869. DOI |
9 | Atta, Ur R. and K. Zaman. 1989. Medicinal plants with hypoglycemic activity. J. Ethnopharmacol. 26, 1-55. DOI |
10 | Chen, X., X. Bai, Y. Liu, L. Tian, J. Zhou, Q. Zhou, J. Fang, and J. Chenl. 2009. Anti-diabetic effects of water extract and crude polysaccharides from tuberous root of Liriope spicata var. prolifera in mice. J. Ethnopharmacol. 122, 205-209. DOI |
11 | Cheng, Y., L. H. Shen, and J. T. Zhang. 2005. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta. Pharmacol. Sin. 26, 143-149. DOI |
12 | Sugimoto, S., S. Nakamura, H. Matsuda, N. Kitagawa, and M. Yoshikawa. 2009. Chemical constituents from seeds of Panax ginseng: structure of new dammarane-type triterpene ketone, panaxadione, and HPLC comparisons of seeds and flesh. Chem. Pharm. Bull. 57, 283-287. DOI |
13 | Xie, J. T., Y. P. Zhou, L. Dey, A. S. Attele, J. A. Wu, M. Gu, K. S. Polonsky, and C. S. Yuan. 2002. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9, 254-258. DOI |
14 | Yue, P. Y., N. K. Mak, Y. K. Cheng, K. W. Leung, T. B. Ng, D. T. Fan, H. W. Yeung, and R. N. Wong. 2007. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin. Med. 2, 6. DOI |
15 | Ng, T. B. 2006. Pharmacological activity of sanchi ginseng (Panax notoginseng). J. Pharm. Pharmacol. 58, 1007-1019. DOI ScienceOn |
16 | Nishijo, H., T. Uwano, Y. M. Zhong, and T. Ono. 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia. J. Pharmacol. Sci. 95, 145-152. DOI |
17 | Rosenbloom, A. L., J. R. Joe, R. S. Young, and W. E. Winter. 1999. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22, 345-354. DOI |
18 | Tawab, M. A., U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz. 2003. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31, 1065-1071. DOI |
19 | Tohda, C., N. Matsumoto, K. Zou, M. R. Meselhy, and K. Komatsu. 2004. Abeta (25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology 29, 860-868. DOI |
20 | Van Gaal, L. F. and I. H. De Leeuw. 2003. Rationale and options for combination therapy in the treatment of type 2 diabetes. Diabetologia 46, 44-50. |
21 | De Sotillo, D. V. R. and M. Hadley. 2002. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 13, 717-726. DOI |
22 | Verreth, W., J. Ganame, A. Mertens, H. Bernar, M. C. Herregods, and P. Holvoet. 2006. Peroxisome proliferator- activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice. Arterioscler. Thromb. Vasc. Biol. 26, 922-928. DOI |
23 | Xie, J. T., H. H. Aung, J. A. Wu, A. S. Attele, and C. S. Yuan. 2002. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am. J. Chin. Med. 30, 187-194. DOI |
24 | DeFronzo, R. A. 1999. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 131, 281-303. DOI ScienceOn |
25 | Gaster, B. and I. B. Hirsch. 1998. The effects of improved glycemic control on complications in type 2 diabetes. Arch. Intern. Med. 158, 134-140. DOI |
26 | Hanefeld, M. and T. Temelkova-Kurktschiev. 2002. Control of post-prandial hyperglycemia- an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr. Metab. Cardiovasc. Dis. 12, 98-107. |
27 | Hou, J. P. 1977. The chemical constituents of ginseng plants. Comp. Med. East West 5, 123-145. DOI |
28 | Jang, Y. J., J. K. Kim, M. S. Lee, I. H. Ham, W. K. Whang, K. H. Kim, and H. J. Kim. 2001. Hypoglycemic and hypolipidemic effects of crude saponin fractions from Panax ginseng and gynostemma pentaphyllum. Yakhak Hoechi 45, 545-556. |
29 | Kim, M. J., K. H. Leem, and H. K. Kim. 2009. Hydrangea dulcis folium preserves b-cell mass in diabetic db/db mice. Food Chem. Toxicol. 47, 1685-1688. DOI |